Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agents
- PMID: 3700462
- PMCID: PMC12253745
- DOI: 10.1007/BF00400758
Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agents
Abstract
The antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III) against the P388 leukemia and against the B16 melanoma was investigated. The test compound showed high activity against these tumor models. The tumor inhibiting effect was in the range or better than the effects of the compounds cyclophosphamide, cisplatin, or 5-fluorouracil, which were tested as positive controls. The effective substance is a new, water soluble, anionic, nitrogen-heterocyclic coordinated, ruthenium species, exhibiting antitumor activity.
Similar articles
-
Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats.J Cancer Res Clin Oncol. 1992;118(3):195-200. doi: 10.1007/BF01410134. J Cancer Res Clin Oncol. 1992. PMID: 1548284 Free PMC article.
-
Synthesis and antitumor activity of triazolium-bis(triazole)-tetrachlororuthenate (III) and bistriazolium-triazolepentachlororuthenate (III). Two representatives of a new class of inorganic antitumor agents.Arzneimittelforschung. 1987 Jul;37(7):770-1. Arzneimittelforschung. 1987. PMID: 3675670
-
Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.Jpn J Cancer Res. 1997 Mar;88(3):316-27. doi: 10.1111/j.1349-7006.1997.tb00383.x. Jpn J Cancer Res. 1997. PMID: 9140117 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090. Health Technol Assess. 2006. PMID: 16545208
Cited by
-
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics.Pharmaceutics. 2022 Apr 28;14(5):954. doi: 10.3390/pharmaceutics14050954. Pharmaceutics. 2022. PMID: 35631543 Free PMC article. Review.
-
A newly synthesized molecule derived from ruthenium cation, with antitumour activity, activates NADPH oxidase in human neutrophils.Biochem J. 1997 Dec 1;328 ( Pt 2)(Pt 2):559-64. doi: 10.1042/bj3280559. Biochem J. 1997. PMID: 9371715 Free PMC article.
-
Comparative antitumor activity of ruthenium derivatives with 5'-deoxy-5-fluorouridine in chemically induced colorectal tumors in SD rats.Cancer Chemother Pharmacol. 1987;19(4):347-9. doi: 10.1007/BF00261487. Cancer Chemother Pharmacol. 1987. PMID: 2954714
-
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry.Molecules. 2019 May 24;24(10):1995. doi: 10.3390/molecules24101995. Molecules. 2019. PMID: 31137659 Free PMC article. Review.
-
Redox modulator iron complexes trigger intrinsic apoptosis pathway in cancer cells.iScience. 2024 May 3;27(6):109899. doi: 10.1016/j.isci.2024.109899. eCollection 2024 Jun 21. iScience. 2024. PMID: 38799569 Free PMC article.
References
-
- Berger MR, Bischoff H, Hermanek P, Schmähl D (1984) Biological characterization and chemotherapy of autochthonous colorectal tumors in rats. In: Klein HO (ed) Advances in the chemotherapy of gastrointestinal cancer. Perimed-Fachbuch-Verlagsgesellschaft, Erlangen, pp 75–81
-
- Clarke MJ (1980) Oncological implications of the chemistry of ruthnium. In: Sigel H (ed) Metal ions in biological systems volume 11, metal complexes as anticancer agents. Marcel Dekker, Inc., Basel, New York, pp 231–276
-
- Cleare MJ, Hydes PC (1980) Antitumor properties of metal complexes. In: Sigel H (ed) Metal ions in biological systems volume II, metal complexes as anticancer agents. Marcel Dekker, Inc., Basel, New York, pp 1–56
-
- Keller HJ, Keppler BK, Schmähl D (1982) Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)-titanium(IV) compounds against Walker 256 carcinosarcoma. Drug Res 8:806–807 - PubMed
-
- Keppler BK, Diez A, Seifried V (1985) Antitumor activity of phenyl substituted dihalogenobis(1-phenyl-1,3-butanedionato)titanium-(IV) compounds. Drug Res 35(II) 12:1832–1836 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources